Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (96)

2023

  1. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

    NMR in Biomedicine, Vol. 36, Núm. 8

  2. Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis

    Biomarker Research, Vol. 11, Núm. 1

  3. Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528] (Redox Biology (2020) 34, (S2213231720304882), (10.1016/j.redox.2020.101528))

    Redox Biology

  4. Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair

    Purinergic Signalling

  5. Defining the metabolic signatures associated with human macrophage polarisation

    Biochemical Society transactions, Vol. 51, Núm. 4, pp. 1429-1436

  6. Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity

    Frontiers in Immunology, Vol. 14

  7. Increased let-7d-5p in non-alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis

    Liver International, Vol. 43, Núm. 8, pp. 1714-1728

  8. Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice

    Molecular Metabolism, Vol. 74

  9. New and Old Key Players in Liver Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  10. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD

    Metabolism: Clinical and Experimental, Vol. 145

  11. Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance

    JHEP Reports, Vol. 5, Núm. 8

  12. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice

    Aging Cell, Vol. 22, Núm. 3